Haemonetics Corporation

United States of America

Back to Profile

1-100 of 288 for Haemonetics Corporation and 4 subsidiaries Sort by
Query
Aggregations
IP Type
        Patent 174
        Trademark 114
Jurisdiction
        United States 143
        World 86
        Canada 37
        Europe 22
Owner / Subsidiary
[Owner] Haemonetics Corporation 253
Hemerus Medical, LLC 14
Global Med Technologies, Inc. 12
Haemoscope Corporation 9
Haemonetics Canada Ltd. 1
Date
2026 April 2
2026 (YTD) 3
2025 20
2024 20
2023 9
See more
IPC Class
A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation 65
A61M 1/38 - Removing constituents from donor blood and returning remainder to body 33
A61M 1/02 - Blood transfusion apparatus 31
A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration 27
G01N 33/49 - Physical analysis of biological material of liquid biological material blood 22
See more
NICE Class
09 - Scientific and electric apparatus and instruments 59
10 - Medical apparatus and instruments 55
42 - Scientific, technological and industrial services, research and design 14
11 - Environmental control apparatus 6
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 6
See more
Status
Pending 34
Registered / In Force 254
  1     2     3        Next Page

1.

WHOLE BLOOD COLLECTION AND STORAGE SYSTEM

      
Application Number US2025051239
Publication Number 2026/085318
Status In Force
Filing Date 2025-10-16
Publication Date 2026-04-23
Owner HEMERUS MEDICAL, LLC (USA)
Inventor Zia, Majid

Abstract

In some embodiments, the invention provides a system for collecting whole blood. In some embodiments, the system comprises two bags containing solutions which are mixed prior to, at the same time as, or shortly after the addition of donated whole blood to one of the bags. In some embodiments, the blood bags of the system are substantially free of the plasticizer di(2- ethylhexyl) phthalate. In some embodiments, all components of the system are substantially free of the plasticizer di(2-ethylhexyl) phthalate.

IPC Classes  ?

2.

SYSTEM AND METHOD FOR INDIVIDUALIZED PLASMA DONATION

      
Application Number US2025048187
Publication Number 2026/072960
Status In Force
Filing Date 2025-09-26
Publication Date 2026-04-02
Owner HAEMONETICS CORPORATION (USA)
Inventor Kasper, Seth

Abstract

A method for collecting plasma includes receiving donor information and demographic information and determining a target volume of plasma to collect based, at least in part, on the received donor information. The method also determines a plasma collection protocol based, at least in part, on the received donor information. The plasma collection protocol has a plurality of collection parameters and a plurality of process parameters. The method may then adjust at least one of the plurality of collection parameters and/or the plurality of process parameters based on the donor information and/or the demographic information. The method also performs a plasma collection procedure according to the determined plasma collection protocol and adjusted collection parameters and/or process parameters. The plasma collection procedure has a plurality of draw cycles and a plurality of return cycles.

IPC Classes  ?

  • A61M 1/38 - Removing constituents from donor blood and returning remainder to body
  • G16H 10/40 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
  • G16H 20/40 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
  • G16H 40/20 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms

3.

SYSTEM AND METHOD FOR INDIVIDUALIZED PLASMA DONATION

      
Application Number 19341846
Status Pending
Filing Date 2025-09-26
First Publication Date 2026-03-26
Owner Haemonetics Corporation (USA)
Inventor
  • Ragusa, Michael
  • Hartmann, Jan
  • Smith, Stephen
  • Kasper, Seth

Abstract

A method for collecting plasma includes receiving donor information and demographic information and determining a target volume of plasma to collect based, at least in part, on the received donor information. The method also determines a plasma collection protocol based, at least in part, on the received donor information. The plasma collection protocol has a plurality of collection parameters and a plurality of process parameters. The method may then adjust at least one of the plurality of collection parameters and/or the plurality of process parameters based on the donor information and/or the demographic information. The method also performs a plasma collection procedure according to the determined plasma collection protocol and adjusted collection parameters and/or process parameters. The plasma collection procedure has a plurality of draw cycles and a plurality of return cycles.

IPC Classes  ?

4.

APHERESIS DEVICE CONTROLLER

      
Application Number 17271448
Status Pending
Filing Date 2019-08-26
First Publication Date 2025-12-25
Owner Haemonetics Corporation (USA)
Inventor Tan, Melvin

Abstract

A controller for a blood processing device has a body that may dock and undock with a first blood processing device to connect the controller to the first blood processing device and disconnect the controller from the first blood processing device. A processor within the controller controls the first blood processing device when the controller is docked with the first blood processing device and remotely controls the first blood processing device when undocked. The controller also has a user interface that displays information regarding the first blood processing device and an ongoing apheresis procedure when the controller is docked to the first blood processing device and when the controller is undocked from the first blood processing device.

IPC Classes  ?

  • A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration
  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation

5.

SYSTEM FOR SCREENING SOURCE PLASMA

      
Application Number US2025029708
Publication Number 2025/240830
Status In Force
Filing Date 2025-05-16
Publication Date 2025-11-20
Owner HAEMONETICS CORPORATION (USA)
Inventor Murphy, Matthew

Abstract

A plasma testing system includes a plasma collection bottle, having a body and an opening. The blood plasma bottle is configured to contain plasma, and a cartridge connectable to the opening of the bottle. The cartridge is configured to seal the opening of the bottle and includes plasma testing circuitry to test the plasma. The system further has a testing platform including at least one receptacle configured to receive the plasma collection bottle and the cartridge. The at least one receptacle has receiving circuitry in communication with the testing circuitry to receive a test result of the plasma test of the plasma.

IPC Classes  ?

  • A61J 1/14 - Containers specially adapted for medical or pharmaceutical purposes DetailsAccessories therefor
  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers

6.

PLASMA CENTER QUEUE MANAGEMENT SYSTEM

      
Application Number 19202533
Status Pending
Filing Date 2025-05-08
First Publication Date 2025-11-13
Owner Haemonetics Corporation (USA)
Inventor Tan, Melvin

Abstract

A method of managing plasma donation throughput of a plasma donor center includes receiving a request message indicating a request from a donor to donate plasma at the plasma donor center. Plasma donor center data is received from two or more of a plasma donor management system, a plasma center queue management system, or a donor plasma donation mobile application. The wait time is determined within the plasma donor center as a function of plasma center data received from at least two of a plasma donor management system, a plasma center queue management system, or a donor plasma donation mobile application. A reservation message is forwarded to a blood establishment computer system regarding the queue position of the donor, the reservation, or both the donor and the reservation, and a confirmation message is forwarded toward including the determined wait time and preferred arrival time for the donor.

IPC Classes  ?

  • G06Q 10/02 - Reservations, e.g. for tickets, services or events
  • G16H 40/20 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms

7.

BLOOD-PRODUCT RECONCILIATION SYSTEM AND METHOD

      
Application Number 19202555
Status Pending
Filing Date 2025-05-08
First Publication Date 2025-11-13
Owner Haemonetics Corporation (USA)
Inventor Tan, Melvin

Abstract

A method and apparatus for managing blood products includes using an image system to capture an image of a container removably holding a plurality of vials containing a blood product, each vial having vial identifying indicia, the image system capturing the vial identifying indicia of each vial, the image system also capturing a visual attribute of the blood product. The captured identifying indicia of each vial is compared to a record having vial information related to the container, and the captured identifying indicia and vial information in the record is used to reconcile the container and plurality of vials to produce a reconciliation. A quality of the blood product as a function of the captured visual attribute is determined, a visual display of the results of the reconciliation and the quality of the blood product is logically produced and forwarded toward a display device.

IPC Classes  ?

  • G06T 7/00 - Image analysis
  • G06K 19/06 - Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code

8.

APHERESIS REGISTRATION SYSTEM

      
Application Number 19202521
Status Pending
Filing Date 2025-05-08
First Publication Date 2025-11-13
Owner Haemonetics Corporation (USA)
Inventor Tan, Melvin

Abstract

A portable apheresis system for separating blood into blood components includes a cellular modem configured to transmit and receive information to and from the apheresis device via a cellular connection, and a connector operatively coupled with the cellular modem. The connector is configured to control the cellular modem to transmit and receive apheresis device registration information, establish, using the cellular modem, a cellular communication connection between an apheresis device and a cellular network after detecting the cellular network, transmit registration information relating to the apheresis device to a registration and connectivity computer software server via the wireless communication connection, receive an apheresis registration response from the registration and connectivity computer software server, the apheresis registration response including information relating to the apheresis device registration process, the registration process causing direct or indirect apheresis device communication with a blood establishment computer system remotely positioned relative to the apheresis device.

IPC Classes  ?

  • A61M 1/02 - Blood transfusion apparatus
  • G16H 40/40 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades

9.

METHOD AND APPARATUS FOR MATCHING ANONYMOUS VITALS DATA TO A BLOOD PRODUCT DONOR RECORD

      
Application Number 19202567
Status Pending
Filing Date 2025-05-08
First Publication Date 2025-11-13
Owner Haemonetics Corporation (USA)
Inventor
  • Tan, Melvin
  • Loitz, Tracey

Abstract

A blood product donation management method includes determining that a donor is at a location associated with a given vitals device at a given time. A blood establishment computer system receives a vitals message with vitals information relating to the donor obtained from the given vitals device, the vitals message being deidentified to include deidentified information about the donor, and is configured to manage donor information and donation processes. A donor identity of the donor is fetched from the donor records database using the location associated with the identifier of the given vitals device and the given time as database indices to identify the donor with donor identification information. The BECS uses a decision-making framework to determine whether the donor can donate blood and transmits a message indicating whether the donor can donate blood.

IPC Classes  ?

  • G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
  • G06F 21/62 - Protecting access to data via a platform, e.g. using keys or access control rules
  • G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment

10.

SYSTEM AND METHOD FOR COLLECTING PLASMA

      
Application Number 19275431
Status Pending
Filing Date 2025-07-21
First Publication Date 2025-11-13
Owner Haemonetics Corporation (USA)
Inventor Ragusa, Michael

Abstract

A method for collecting plasma includes determining the weight, height, and hematocrit of a donor, and calculating a donor plasma volume and a target plasma collection volume. The target plasma collection volume is based on the donor plasma volume and a target percentage of plasma. The method then withdraws blood from the donor through a line connected to a blood component separation device, and introduces anticoagulant into the withdrawn blood. The blood component separation device separates the blood into a plasma component and a second blood component, and the plasma component is collected from the blood component separation device and into a plasma collection container. The method may then calculate the volume of pure plasma collected within the plasma collection container, and continue processing/collecting until the calculated volume of pure plasma equals the target plasma collection volume.

IPC Classes  ?

  • A61M 1/38 - Removing constituents from donor blood and returning remainder to body
  • A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration
  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation

11.

DISPOSABLE CARTRIDGE FOR CLASSIFICATION OF ANTICOAGULANT AND METHOD OF USE

      
Application Number 19279581
Status Pending
Filing Date 2025-07-24
First Publication Date 2025-11-13
Owner Haemonetics Corporation (USA)
Inventor
  • Delgiacco, Gerard R.
  • Shafizadeh, Ebrahim

Abstract

Disposable cartridges and methods for detecting and classifying an anticoagulant at a therapeutically relevant amount or higher in a patient. The cartridges include a plurality of chambers, as well as fluidic couplings between chambers. Calcium chloride, Russel Viper Venom (RVV), an ecarin reagent, a Factor Xa reagent, protamine, kaolin, tissue factor, and combinations thereof may be included in a given chamber.

IPC Classes  ?

  • G01N 33/86 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving blood coagulating time
  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers

12.

BLOOD STORAGE CONTAINER CONTAINING AQUEOUS COMPOSITION FOR THE STORAGE OF RED BLOOD CELLS

      
Application Number 18951184
Status Pending
Filing Date 2024-11-18
First Publication Date 2025-11-06
Owner Hemerus Medical, LLC (USA)
Inventor Zia, Majid

Abstract

A blood storage container along with an aqueous composition for the storage of packed red blood cells is described. In a preferred embodiment, the container is not made of DEHP plasticizer. In some embodiments, the container is made from a polymeric material and a non-DEHP plasticizer. In some embodiments, the aqueous composition is made of about 1 to about 3 mM adenine, about 20 to about 115 mM dextrose, about 15 to about 60 unmetabolizable membrane-protectant sugar, about 20 to about 30 mM sodium bicarbonate, and about 4 to about 20 mM disodium phosphate. In a most preferred embodiment, the DEHP-lacking container is made from a PVC polymeric material and a DINCH plasticizer and the aqueous composition is made of about 2 mM adenine, about 80 mM dextrose, 55 mM unmetabolizable membrane-protectant sugar, about 26 mM sodium bicarbonate, and about 12 mM disodium phosphate.

IPC Classes  ?

  • A61J 1/10 - Bag-type containers
  • A01N 1/126 - Physiologically active agents, e.g. antioxidants or nutrients
  • A01N 1/146 - Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
  • A61J 1/05 - Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids
  • A61J 1/14 - Containers specially adapted for medical or pharmaceutical purposes DetailsAccessories therefor

13.

SYSTEM AND METHOD FOR ATTACHING A REMOVABLE ACCESSORY OR WIRELESS TRACKING DEVICE TO A PLASMA STORAGE CONTAINER

      
Application Number US2025023442
Publication Number 2025/217046
Status In Force
Filing Date 2025-04-07
Publication Date 2025-10-16
Owner HAEMONETICS CORPORATION (USA)
Inventor Tan, Melvin

Abstract

A blood product container with removable accessory includes a container body defining the structure of the blood product container and defining an interior. The container body includes a main body portion, a top portion, a neck portion extending from the main body portion to the top portion, and a bottom portion. The container also has a container top configured to seal an opening of the blood product container. An attachment location is located on the container body and receives a removable accessory. The removable accessory is secured to the blood product container when received by the attachment location. The removable accessory may be a tracking device with a switch that activates the tracking device when closed and deactivates the tracking device when open. The switch is normally open when the tracking device is not secured to the container and closed when the tracking device is secured to the container.

IPC Classes  ?

  • A61J 1/05 - Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids
  • A61J 1/14 - Containers specially adapted for medical or pharmaceutical purposes DetailsAccessories therefor
  • B65D 25/00 - Details of other kinds or types of rigid or semi-rigid containers

14.

SYSTEM AND METHOD FOR DEPLOYING A HEMOSTATIC IMPLANT IN A TISSUE TRACT

      
Application Number 19089255
Status Pending
Filing Date 2025-03-25
First Publication Date 2025-10-02
Owner Haemonetics Corporation (USA)
Inventor Jen, Jimmy

Abstract

An apparatus is provided for sealing a blood vessel wall penetration disposed at an end of a tissue tract. The apparatus, in one embodiment, includes a shaft having a proximal end and a distal end; an occlusion element near the distal end of the shaft; a hemostatic implant disposed over or adjacent to an exterior surface of the shaft proximal to the occlusion element, said hemostatic implant being hydratable to expand to occlude the tissue tract when exposed to body fluids within the tissue tract; a sleeve peelably disposed over an outer surface of the hemostatic implant and proximal to the occlusion element; and wherein peeling of the sleeve exposes the hemostatic implant such that the hemostatic implant expands and occludes the tissue tract.

IPC Classes  ?

  • A61B 17/00 - Surgical instruments, devices or methods

15.

SYSTEM AND METHOD FOR DEPLOYING A HEMOSTATIC IMPLANT IN A TISSUE TRACT

      
Application Number US2025020741
Publication Number 2025/207403
Status In Force
Filing Date 2025-03-20
Publication Date 2025-10-02
Owner HAEMONETICS CORPORATION (USA)
Inventor Jen, Jimmy

Abstract

An apparatus is provided for sealing a blood vessel wall penetration disposed at an end of a tissue tract. The apparatus, in one embodiment, includes a shaft having a proximal end and a distal end; an occlusion element near the distal end of the shaft; a hemostatic implant disposed over or adjacent to an exterior surface of the shaft proximal to the occlusion element, said hemostatic implant being hydratable to expand to occlude the tissue tract when exposed to body fluids within the tissue tract; a sleeve peelably disposed over an outer surface of the hemostatic implant and proximal to the occlusion element; and wherein peeling of the sleeve exposes the hemostatic implant such that the hemostatic implant expands and occludes the tissue tract.

IPC Classes  ?

  • A61B 17/00 - Surgical instruments, devices or methods
  • A61M 25/06 - Body-piercing guide needles or the like

16.

SYSTEM AND METHOD FOR COLLECTING PLASMA

      
Application Number 19202281
Status Pending
Filing Date 2025-05-08
First Publication Date 2025-08-28
Owner Haemonetics Corporation (USA)
Inventor Ragusa, Michael

Abstract

A method for collecting plasma includes determining the weight and hematocrit of a donor, and inserting a venous-access device into the donor. The method then withdraws blood from the donor through a draw line connected to a blood component separation device, and introduces anticoagulant into the withdrawn blood. The blood component separation device separates the blood into a plasma component and a second blood component, and the plasma component is collected from the blood component separation device and into a plasma collection container. The method may then calculate (1) a percentage of anticoagulant in the collected plasma component, and (2) a volume of pure plasma collected within the plasma collection container. The volume of pure plasma may be based, at least in part, on the calculated percentage of anticoagulant. The method may continue until a target volume of pure plasma is collected within the plasma collection container.

IPC Classes  ?

  • A61M 1/02 - Blood transfusion apparatus
  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
  • A61M 1/38 - Removing constituents from donor blood and returning remainder to body
  • G01N 15/05 - Investigating sedimentation of particle suspensions in blood

17.

TORTUOUS PATH FILTER FOR THE PRODUCTION OF TRANSFUSION-READY RECONSTITUTED PLASMA

      
Application Number 19189001
Status Pending
Filing Date 2025-04-24
First Publication Date 2025-08-07
Owner Hemerus Medical, LLC (USA)
Inventor
  • Zia, Majid
  • Wilker, Nancy C

Abstract

A tortuous path filter for filtering reconstituted plasma, the filter comprising at least two layers of fibers, single-layer filters, or beads, wherein the filter lacks or substantially lacks pores defining a lumen, said lumen having a diameter of larger than (100) microns along a straight path through the filter. The invention provides devices including a tortuous path filter, and methods for producing transfusion-ready plasma comprising: (a) reconstituting dried plasma to produce reconstituted plasma; and (b) passing said reconstituted plasma through the tortuous path filter to produce transfusion-ready plasma.

IPC Classes  ?

  • A61M 1/02 - Blood transfusion apparatus
  • B01D 29/01 - Filters with filtering elements stationary during filtration, e.g. pressure or suction filters, not covered by groups Filtering elements therefor with flat filtering elements

18.

System and method for collecting plasma

      
Application Number 19077384
Grant Number 12377204
Status In Force
Filing Date 2025-03-12
First Publication Date 2025-06-26
Grant Date 2025-08-05
Owner Haemonetics Corporation (USA)
Inventor Ragusa, Michael

Abstract

A method for collecting plasma includes determining the weight, height, and hematocrit of a donor, and calculating a donor plasma volume and a target plasma collection volume. The target plasma collection volume is based on the donor plasma volume and a target percentage of plasma. The method then withdraws blood from the donor through a line connected to a blood component separation device, and introduces anticoagulant into the withdrawn blood. The blood component separation device separates the blood into a plasma component and a second blood component, and the plasma component is collected from the blood component separation device and into a plasma collection container. The method may then calculate the volume of pure plasma collected within the plasma collection container, and continue processing/collecting until the calculated volume of pure plasma equals the target plasma collection volume.

IPC Classes  ?

  • A61M 1/38 - Removing constituents from donor blood and returning remainder to body
  • A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration
  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation

19.

PLASMAPHERESIS CENTRIFUGE BOWL WITH STATIONARY ACTUATING SEAL

      
Application Number US2024058736
Publication Number 2025/122786
Status In Force
Filing Date 2024-12-05
Publication Date 2025-06-12
Owner HAEMONETICS CORPORATION (USA)
Inventor
  • Ragusa, Michael
  • Korytko, Taylor
  • Zhao, Melinda
  • Rasmussen, Kelly
  • Forkus, Paul
  • Merten, Thomas
  • Duross, Ryan

Abstract

A plasmapheresis centrifuge bowl includes an outer body that is rotatable about a longitudinal axis of the plasmapheresis centrifuge bowl. The outer body has a main body defining an interior, a neck portion extending proximal to the main body, and a shoulder connecting the main body and the neck portion. Within the interior, the bowl has a separation region, and rotation of the bowl separates whole blood within the separation region into a first blood component and a second blood component. The bowl also includes an actuating seal mechanism that transitions between an open state when the plasmapheresis centrifuge bowl is rotating and a closed state when the plasmapheresis centrifuge bowl is not rotating.

IPC Classes  ?

  • B04B 7/08 - Rotary bowls
  • B04B 1/12 - Centrifuges with rotary bowls provided with solid jackets for separating predominantly liquid mixtures with or without solid particles with discharging outlets in the plane of the maximum diameter of the bowl with continuous discharge
  • A61M 1/38 - Removing constituents from donor blood and returning remainder to body

20.

PLASMAPHERESIS CENTRIFUGE BOWL WITH STATIONARY ACTUATING SEAL

      
Document Number 03313596
Status Pending
Filing Date 2024-12-05
Open to Public Date 2025-06-12
Owner
  • HAEMONETICS CORPORATION (USA)
  • RAGUSA, Michael (USA)
  • KORYTKO, Taylor (USA)
  • ZHAO, Melinda (USA)
  • RASMUSSEN, Kelly (USA)
  • FORKUS, Paul (USA)
  • MERTEN, Thomas (USA)
  • DUROSS, Ryan (USA)
Inventor
  • Ragusa, Michael
  • Korytko, Taylor
  • Zhao, Melinda
  • Rasmussen, Kelly
  • Forkus, Paul
  • Merten, Thomas
  • Duross, Ryan

Abstract

A plasmapheresis centrifuge bowl includes an outer body that is rotatable about a longitudinal axis of the plasmapheresis centrifuge bowl. The outer body has a main body defining an interior, a neck portion extending proximal to the main body, and a shoulder connecting the main body and the neck portion. Within the interior, the bowl has a separation region, and rotation of the bowl separates whole blood within the separation region into a first blood component and a second blood component. The bowl also includes an actuating seal mechanism that transitions between an open state when the plasmapheresis centrifuge bowl is rotating and a closed state when the plasmapheresis centrifuge bowl is not rotating.

IPC Classes  ?

  • A61M 1/38 - Removing constituents from donor blood and returning remainder to body
  • B04B 1/12 - Centrifuges with rotary bowls provided with solid jackets for separating predominantly liquid mixtures with or without solid particles with discharging outlets in the plane of the maximum diameter of the bowl with continuous discharge
  • B04B 7/08 - Rotary bowls

21.

System and method for collecting plasma

      
Application Number 18955269
Grant Number 12324873
Status In Force
Filing Date 2024-11-21
First Publication Date 2025-03-13
Grant Date 2025-06-10
Owner Haemonetics Corporation (USA)
Inventor Ragusa, Michael

Abstract

A method for collecting plasma includes determining the weight and hematocrit of a donor, and inserting a venous-access device into the donor. The method then withdraws blood from the donor through a draw line connected to a blood component separation device, and introduces anticoagulant into the withdrawn blood. The blood component separation device separates the blood into a plasma component and a second blood component, and the plasma component is collected from the blood component separation device and into a plasma collection container. The method may then calculate (1) a percentage of anticoagulant in the collected plasma component, and (2) a volume of pure plasma collected within the plasma collection container. The volume of pure plasma may be based, at least in part, on the calculated percentage of anticoagulant. The method may continue until a target volume of pure plasma is collected within the plasma collection container.

IPC Classes  ?

  • A61M 1/02 - Blood transfusion apparatus
  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
  • A61M 1/38 - Removing constituents from donor blood and returning remainder to body
  • G01N 15/05 - Investigating sedimentation of particle suspensions in blood

22.

BLOODTRACK

      
Application Number 019138085
Status Registered
Filing Date 2025-02-03
Registration Date 2025-06-22
Owner Haemonetics Corporation (USA)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

Medical apparatus for cooling blood, dispensing blood; medical apparatus for the storage and preservation of bodily fluids, organs, tissues.

23.

BLOODTRACK

      
Application Number 237750600
Status Pending
Filing Date 2025-01-31
Owner Haemonetics Corporation (USA)
NICE Classes  ?
  • 10 - Medical apparatus and instruments
  • 11 - Environmental control apparatus

Goods & Services

(1) Medical apparatus in the nature of a dispenser, for cooling and dispensing blood, namely, a temperature-controlled dispenser for storing and dispensing blood (2) Refrigerators for the preservation and storage of bodily fluids, organs, tissues

24.

BLOODTRACK

      
Serial Number 98925206
Status Registered
Filing Date 2024-12-27
Registration Date 2026-07-14
Owner Haemonetics Corporation (USA)
NICE Classes  ?
  • 10 - Medical apparatus and instruments
  • 11 - Environmental control apparatus

Goods & Services

Medical apparatus for cooling blood, dispensing blood Refrigerators for medical storage purposes for the preservation of bodily fluids, organs, and tissues

25.

Health care provider data systems processing and analytics

      
Application Number 18798949
Grant Number 12537095
Status In Force
Filing Date 2024-08-09
First Publication Date 2024-12-05
Grant Date 2026-01-27
Owner Haemonetics Corporation (USA)
Inventor
  • Tan, Melvin
  • Odeen, James
  • Cairns, Christopher
  • Sheehan, Ronald

Abstract

A method for generating a directive for maintaining an objective includes integrating a control center system with a plurality of healthcare provider data systems and obtaining information from the healthcare provider data system(s). The method may then use artificial intelligence to correlate the obtained information against an identified business objective of a donation center and generate, using a heuristic model, a directive to the donation center(s) to achieve the identified business objective. The method may then present the directive a user and/or user system such that the directive may carried out.

IPC Classes  ?

  • G16H 40/20 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
  • G06N 5/01 - Dynamic search techniquesHeuristicsDynamic treesBranch-and-bound
  • G06Q 10/0639 - Performance analysis of employeesPerformance analysis of enterprise or organisation operations
  • G16H 40/40 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
  • G06Q 50/22 - Social work or social welfare, e.g. community support activities or counselling services

26.

Method and Retainer for Hemostasis Testing

      
Application Number 18656658
Status Pending
Filing Date 2024-05-07
First Publication Date 2024-11-07
Owner Haemonetics Corporation (USA)
Inventor
  • Delmenico, Peter
  • Lopez-Espina, Carlos G.
  • Raviv, Gabriel

Abstract

A method of testing blood hemostasis may include introducing a blood sample into a fluid processing structure, where the fluid processing structure contains a reagent, for example in a passage. The fluid sample may be processed by passing a portion through the fluid processing structure so as to contact the reagent. The processed portion is then communicated to a sample retention structure of the fluid processing structure. Testing is accomplished by vibratory excitation of the processed portion to obtain data indicative of at least one hemostasis parameter.

IPC Classes  ?

  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
  • G01N 11/16 - Investigating flow properties of materials, e.g. viscosity or plasticityAnalysing materials by determining flow properties by moving a body within the material by measuring damping effect upon oscillatory body
  • G01N 29/032 - Analysing fluids by measuring attenuation of acoustic waves
  • G01N 29/036 - Analysing fluids by measuring frequency or resonance of acoustic waves
  • G01N 29/24 - Probes
  • G01N 33/49 - Physical analysis of biological material of liquid biological material blood

27.

FORMULATIONS AND METHODS FOR COLLECTING AND STORING BLOOD AND BLOOD PRODUCTS

      
Document Number 03286915
Status Pending
Filing Date 2024-03-28
Open to Public Date 2024-10-03
Owner HEMERUS MEDICAL, LLC (USA)
Inventor
  • Zia, Majid
  • Hess, John R.
  • Wilker, Nancy C.

IPC Classes  ?

  • A61K 9/14 - Particulate form, e.g. powders
  • A61K 9/19 - Particulate form, e.g. powders lyophilised
  • A61K 9/20 - Pills, lozenges or tablets
  • A61K 31/19 - Carboxylic acids, e.g. valproic acid
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • A61P 7/02 - Antithrombotic agentsAnticoagulantsPlatelet aggregation inhibitors

28.

FORMULATIONS AND METHODS FOR COLLECTING AND STORING BLOOD AND BLOOD PRODUCTS

      
Application Number US2024022068
Publication Number 2024/206693
Status In Force
Filing Date 2024-03-28
Publication Date 2024-10-03
Owner HEMERUS MEDICAL, LLC (USA)
Inventor
  • Zia, Majid
  • Hess, John, R.
  • Wilker, Nancy, C.

Abstract

In various aspects, the invention provides dry (or solid) compositions or formulations (in the form of powder, capsules, and tablets) to be mixed with donated whole blood. In another aspect, the invention provides dry or solid compositions or formulations (in the form of powder, capsules, and tablets) to be mixed with a donated blood product such as red blood cells. In further aspects, the invention provides a blood bag comprising an interior containing dry (or solid) compositions or formulations (in the form of powder, capsules, and tablets) to be mixed with donated whole blood or a blood product thereof. In further aspects, the invention provides whole blood, or a blood product thereof, mixed with a dry formulation as described herein.

IPC Classes  ?

  • A61K 31/19 - Carboxylic acids, e.g. valproic acid
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
  • A61K 9/14 - Particulate form, e.g. powders
  • A61K 9/19 - Particulate form, e.g. powders lyophilised
  • A61K 9/20 - Pills, lozenges or tablets
  • A61P 7/02 - Antithrombotic agentsAnticoagulantsPlatelet aggregation inhibitors

29.

SYSTEM AND METHOD FOR COLLECTING PLASMA

      
Application Number 18606761
Status Pending
Filing Date 2024-03-15
First Publication Date 2024-09-05
Owner Haemonetics Corporation (USA)
Inventor Ragusa, Michael

Abstract

A method for collecting plasma includes determining the weight, height, and hematocrit of a donor, and calculating a donor plasma volume and a target plasma collection volume. The target plasma collection volume is based on the donor plasma volume and a target percentage of plasma. The method then withdraws blood from the donor through a line connected to a blood component separation device, and introduces anticoagulant into the withdrawn blood. The blood component separation device separates the blood into a plasma component and a second blood component, and the plasma component is collected from the blood component separation device and into a plasma collection container. The method may then calculate the volume of pure plasma collected within the plasma collection container, and continue processing/collecting until the calculated volume of pure plasma equals the target plasma collection volume.

IPC Classes  ?

  • A61M 1/38 - Removing constituents from donor blood and returning remainder to body
  • A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration
  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation

30.

CONTAINER FOR BLOOD COMPONENT COOLING AND FREEZING

      
Application Number 18630118
Status Pending
Filing Date 2024-04-09
First Publication Date 2024-08-15
Owner Haemonetics Corporation (USA)
Inventor
  • Zimenkov, Yuri
  • Piazzarolo, Bruno
  • Kommireddy, Dinesh
  • Yue, Shinji
  • Fallon, Tim

Abstract

A blood component cooling container includes a body portion having a proximal end and a distal end. The body portion defines an interior volume, and includes a plurality of cooling vanes that extend radially outward from the body portion. The cooling vanes increase the external surface area of the blood component cooling container. The blood component cooling container also has an opening within the body portion and configured to receive collected plasma.

IPC Classes  ?

  • A61J 1/16 - Holders for containers
  • A61J 1/05 - Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids
  • A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration

31.

DISPOSABLE CARTRIDGE FOR CLASSIFICATION OF ANTICOAGULANT AND METHOD OF USE

      
Application Number US2024012894
Publication Number 2024/163247
Status In Force
Filing Date 2024-01-25
Publication Date 2024-08-08
Owner HAEMONETICS CORPORATION (USA)
Inventor
  • Delgiacco, Gerard, R.
  • Shafizadeh, Ebrahim

Abstract

Disposable cartridges and methods for detecting and classifying an anticoagulant at a therapeutically relevant amount or higher in a patient. The cartridges include a plurality of chambers, as well as fluidic couplings between chambers. Calcium chloride, Russel Viper Venom (RVV), an ecarin reagent, a Factor Xa reagent, protamine, kaolin, tissue factor, and combinations thereof may be included in a given chamber.

IPC Classes  ?

  • C12Q 1/56 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
  • G01N 33/49 - Physical analysis of biological material of liquid biological material blood
  • G01N 33/86 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving blood coagulating time

32.

SYSTEM AND SOLUTION FOR IMPROVED WHOLE BLOOD STORAGE

      
Application Number 18553595
Status Pending
Filing Date 2022-04-07
First Publication Date 2024-06-06
Owner Hemerus Medical, LLC (USA)
Inventor
  • Hess, John
  • Zia, Majid

Abstract

A whole blood storage system that includes whole blood leukoreduction with pH optimization for improved RBC storage. Such a system can provide leukoreduced whole blood for field medical use, but would preserve the RBCs and most plasma coagulation activity for at least about 2 weeks, or about 3 weeks, or about 4 weeks, or about 5 weeks or about 6 weeks so that the units would not go to waste.

IPC Classes  ?

33.

TORTUOUS PATH FILTER FOR THE PRODUCTION OF TRANSFUSION-READY RECONSTITUTED PLASMA

      
Application Number US2023036332
Publication Number 2024/097146
Status In Force
Filing Date 2023-10-31
Publication Date 2024-05-10
Owner HEMERUS MEDICAL, LLC (USA)
Inventor
  • Zia, Majid
  • Wilker, Nancy, C.

Abstract

A tortuous path filter for filtering reconstituted plasma, the filter comprising at least two layers of fibers, single-layer filters, or beads, wherein the filter lacks or substantially lacks pores defining a lumen, said lumen having a diameter of larger than (100) microns along a straight path through the filter. The invention provides devices including a tortuous path filter, and methods for producing transfusion-ready plasma comprising: (a) reconstituting dried plasma to produce reconstituted plasma; and (b) passing said reconstituted plasma through the tortuous path filter to produce transfusion-ready plasma.

IPC Classes  ?

34.

DONOR360

      
Application Number 1785651
Status Registered
Filing Date 2024-02-05
Registration Date 2024-02-05
Owner Haemonetics Corporation (USA)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

Downloadable computer application software for mobile phones and computers, namely, downloadable software for use by potential blood or plasma donors to see donation history, find donation drives and schedule appointments, receive education about the donation process, complete health history questionnaires, receive notification of use of donated blood or plasma; downloadable computer application software for mobile phones and computers, namely, downloadable software for use by blood or plasma donation center operators for donation trend analysis, to target and identify donors and prospective donors for marketing message outreach via social media, e-mail, or SMS, conduct donor surveys, and for providing information about the donor to donation center workers to enhance the donor's in-center experience; computer application software for mobile phones and computers, namely, recorded software for use by potential blood or plasma donors to see donation history, find donation drives and schedule appointments, receive education about the donation process, complete health history questionnaires, receive notification of use of donated blood or plasma; computer application software for mobile phones and computers, namely, recorded software for use by blood or plasma donation center operators for donation trend analysis, to target and identify donors and prospective donors for marketing message outreach via social media, e-mail, or SMS, conduct donor surveys, and for providing information about the donor to donation center workers to enhance the donor's in-center experience.

35.

DEVICE360

      
Application Number 1783202
Status Registered
Filing Date 2024-02-05
Registration Date 2024-02-05
Owner Haemonetics Corporation (USA)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

Downloadable computer software for mobile phones and computers, namely, software for use in blood and blood plasma donation center operation.

36.

CENTER360

      
Application Number 1784027
Status Registered
Filing Date 2024-02-05
Registration Date 2024-02-05
Owner Haemonetics Corporation (USA)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

Downloadable computer software for mobile phones and computers, namely, software for use by blood or blood plasma donation centers to collect and display information regarding blood plasma donor flow and activity within the center; downloadable computer software for mobile phones and computers, namely, software for use by blood or plasma donation center operators for center employee performance analysis.

37.

Bracket, thrombelastography device, and support system

      
Application Number 18380967
Grant Number 12169195
Status In Force
Filing Date 2023-10-17
First Publication Date 2024-02-08
Grant Date 2024-12-17
Owner Haemonetics Corporation (USA)
Inventor
  • Xiao, Jian
  • Yu, Bangzhong
  • Jiang, Feng

Abstract

A bracket a thrombelastography device, and a support system are disclosed. The bracket comprises: a fixed support part (101), a movable support part (102), and a connection part (103). The connection part comprises a first fixing connection member (1031) and a second fixing connection member (1032). The first fixing connection member is fixedly connected to the fixed support part; the second fixing connection member is fixedly connected to the movable support part; the first fixing connection member is connected to the second fixing connection member in point contact fashion, such that the first fixing connection member and the second fixing connection member can rotate relative to each other; the movable support part is fixedly connected to a supported object; when driven by the supported object, the movable support part rotates relative to the fixed support part by means of the point contact between the first fixing connection member and the second fixing connection member. The thrombelastography device comprises a rotational shaft and a bracket. The rotational resistance to the supported object when it rotates can be reduced.

IPC Classes  ?

  • G01N 33/49 - Physical analysis of biological material of liquid biological material blood
  • G01N 11/06 - Investigating flow properties of materials, e.g. viscosity or plasticityAnalysing materials by determining flow properties by measuring flow of the material through a restricted passage, e.g. tube, aperture by timing the outflow of a known quantity
  • G01N 11/14 - Investigating flow properties of materials, e.g. viscosity or plasticityAnalysing materials by determining flow properties by moving a body within the material by using rotary bodies, e.g. vane
  • G01N 11/16 - Investigating flow properties of materials, e.g. viscosity or plasticityAnalysing materials by determining flow properties by moving a body within the material by measuring damping effect upon oscillatory body
  • G01N 33/86 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving blood coagulating time

38.

CENTER360

      
Application Number 230888200
Status Registered
Filing Date 2024-02-06
Registration Date 2026-06-26
Owner Haemonetics Corporation (USA)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

(1) Downloadable computer software for mobile phones and computers, namely, software for use by blood or blood plasma donation centers to collect and display information regarding blood plasma donor flow and activity within the center; downloadable computer software for mobile phones and computers, namely, software for use by blood or plasma donation center operators for center employee performance analysis

39.

DEVICE360

      
Application Number 230888900
Status Registered
Filing Date 2024-02-06
Registration Date 2026-01-16
Owner Haemonetics Corporation (USA)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

(1) Downloadable computer software for mobile phones and computers, namely, software for use by blood or blood plasma donation centers to collect and display information regarding blood plasma donor flow and activity within the center; downloadable computer software for mobile phones and computers, namely, software for use by blood or plasma donation center operators for center employee performance analysis

40.

DEVICE360

      
Application Number 018983365
Status Registered
Filing Date 2024-02-06
Registration Date 2024-06-20
Owner Haemonetics Corporation (USA)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

Downloadable computer software for mobile phones and computers, namely, software for use in blood and blood plasma donation center operation.

41.

CENTER360

      
Application Number 018983404
Status Registered
Filing Date 2024-02-06
Registration Date 2024-06-21
Owner Haemonetics Corporation (USA)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

Downloadable computer software for mobile phones and computers, namely, software for use by blood or blood plasma donation centers to collect and display information regarding blood plasma donor flow and activity within the center; downloadable computer software for mobile phones and computers, namely, software for use by blood or plasma donation center operators for center employee performance analysis.

42.

DONOR360

      
Application Number 230889000
Status Registered
Filing Date 2024-02-06
Registration Date 2025-11-21
Owner Haemonetics Corporation (USA)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

(1) Downloadable computer application software for mobile phones and computers, namely, downloadable software for use by potential blood or plasma donors to see donation history, find donation drives and schedule appointments, receive education about the donation process, complete health history questionnaires, receive notification of use of donated blood or plasma; downloadable computer application software for mobile phones and computers, namely, downloadable software for use by blood or plasma donation center operators for donation trend analysis, to target and identify donors and prospective donors for marketing message outreach via social media, e-mail, or SMS, conduct donor surveys, and for providing information about the donor to donation center workers to enhance the donor's in-center experience; computer application software for mobile phones and computers, namely, recorded software for use by potential blood or plasma donors to see donation history, find donation drives and schedule appointments, receive education about the donation process, complete health history questionnaires, receive notification of use of donated blood or plasma; computer application software for mobile phones and computers, namely, recorded software for use by blood or plasma donation center operators for donation trend analysis, to target and identify donors and prospective donors for marketing message outreach via social media, e-mail, or SMS, conduct donor surveys, and for providing information about the donor to donation center workers to enhance the donor's in-center experience

43.

DONOR360

      
Application Number 018983210
Status Registered
Filing Date 2024-02-06
Registration Date 2024-06-20
Owner Haemonetics Corporation (USA)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

Downloadable computer application software for mobile phones and computers, namely, downloadable software for use by potential blood or plasma donors to see donation history, find donation drives and schedule appointments, receive education about the donation process, complete health history questionnaires, receive notification of use of donated blood or plasma; downloadable computer application software for mobile phones and computers, namely, downloadable software for use by blood or plasma donation center operators for donation trend analysis, to target and identify donors and prospective donors for marketing message outreach via social media, e-mail, or SMS, conduct donor surveys, and for providing information about the donor to donation center workers to enhance the donor's in-center experience; computer application software for mobile phones and computers, namely, recorded software for use by potential blood or plasma donors to see donation history, find donation drives and schedule appointments, receive education about the donation process, complete health history questionnaires, receive notification of use of donated blood or plasma; computer application software for mobile phones and computers, namely, recorded software for use by blood or plasma donation center operators for donation trend analysis, to target and identify donors and prospective donors for marketing message outreach via social media, e-mail, or SMS, conduct donor surveys, and for providing information about the donor to donation center workers to enhance the donor's in-center experience.

44.

Blood storage container containing aqueous composition for the storage of red blood cells

      
Application Number 18209877
Grant Number 12178779
Status In Force
Filing Date 2023-06-14
First Publication Date 2023-10-26
Grant Date 2024-12-31
Owner Hemerus Medical, LLC (USA)
Inventor Zia, Majid

Abstract

A blood storage container along with an aqueous composition for the storage of packed red blood cells is described. In a preferred embodiment, the container is not made of DEHP plasticizer. In some embodiments, the container is made from a polymeric material and a non-DEHP plasticizer. In some embodiments, the aqueous composition is made of about 1 to about 3 mM adenine, about 20 to about 115 mM dextrose, about 15 to about 60 unmetabolizable membrane-protectant sugar, about 20 to about 30 mM sodium bicarbonate, and about 4 to about 20 mM disodium phosphate. In a most preferred embodiment, the DEHP-lacking container is made from a PVC polymeric material and a DINCH plasticizer and the aqueous composition is made of about 2 mM adenine, about 80 mM dextrose, 55 mM unmetabolizable membrane-protectant sugar, about 26 mM sodium bicarbonate, and about 12 mM disodium phosphate.

IPC Classes  ?

  • A61J 1/10 - Bag-type containers
  • A01N 1/02 - Preservation of living parts
  • A61J 1/05 - Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids
  • A61J 1/14 - Containers specially adapted for medical or pharmaceutical purposes DetailsAccessories therefor

45.

Continuous flow separation chamber

      
Application Number 18135980
Grant Number 12042595
Status In Force
Filing Date 2023-04-18
First Publication Date 2023-08-31
Grant Date 2024-07-23
Owner Haemonetics Corporation (USA)
Inventor
  • Murphy, Matthew
  • Uhlmann, Dominique
  • Powers, Edward
  • Ragusa, Michael
  • Pagès, Etienne

Abstract

A continuous flow centrifuge bowl includes a rotatable outer body, and a top and bottom core that are rotatable with the outer body. The bottom core has a wall extending proximally from a bottom wall. The proximally extending wall is radially outward from at least a portion of the top core and, together with the top core, defines a primary separation region in which initial separation of the whole blood occurs. The bowl may also have a secondary separation region located between the top core and the outer body, and a rotary seal that couples an inlet port and two outlet ports to the outer body. The inlet port may be connected to an inlet tube that extends distally into a whole blood introduction region. Additionally, one of the outlet ports may be connected to an extraction tube that extends into a region below the bottom core.

IPC Classes  ?

  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
  • B04B 5/04 - Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers
  • B04B 13/00 - Control arrangements specially designed for centrifugesProgramme control of centrifuges

46.

HEMERUS

      
Serial Number 98148105
Status Registered
Filing Date 2023-08-24
Registration Date 2025-11-11
Owner Hemerus Medical, LLC ()
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 10 - Medical apparatus and instruments

Goods & Services

Chemical preparations for scientific purposes, namely, chemical solutions used to aid in the anticoagulation, preservation, or storage of whole blood and cellular and non-cellular blood products, in particular plasma, platelets, and red blood cells for scientific and laboratory purposes; chemical preparations for the manufacture of tubing, bags, and filters for collecting or storing whole blood and cellular and non-cellular blood products, in particular plasma, platelets, white blood cells, plasma proteins in the nature of immunoglobulins, and red blood cells Medical devices, namely, kits for the collection, preservation, or storage of whole blood and cellular and non-cellular blood products, in particular plasma, platelets, white blood cells, and red blood cells, comprised of medical tubing for transfusions, empty blood storage bags, and medical whole blood and cellular and non-cellular blood products, in particular plasma, platelets, plasma proteins in the nature of immunoglobulins, and red blood cells, as well as anticoagulation and chemical storage solutions; filters for blood and blood components for medical use, namely, filters for reducing leukocytes and white blood cells in collected whole blood, and cellular and non-cellular blood products, in particular plasma, platelets, and red blood cells

47.

DEVICE360

      
Serial Number 98122627
Status Registered
Filing Date 2023-08-08
Registration Date 2026-06-30
Owner Haemonetics Corporation (USA)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

Downloadable computer software for mobile phones and computers, namely, software for use in blood and blood plasma donation center operation

48.

CENTER360

      
Serial Number 98122637
Status Pending
Filing Date 2023-08-08
Owner Haemonetics Corporation (USA)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

Downloadable computer software for mobile phones and computers, namely, software for use by blood and blood plasma donation centers to collect and display information regarding movement of blood plasma donors and activity within the center; downloadable computer software for mobile phones and computers, namely, software for use by blood and blood plasma donation center operators for center employee performance analysis

49.

SOLX

      
Serial Number 98074886
Status Registered
Filing Date 2023-07-07
Registration Date 2025-11-11
Owner Hemerus Medical, LLC ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Chemical preparations for scientific purposes, namely, chemical solutions used to aid in the storage or preservation of red blood cells for scientific and laboratory purposes

50.

APEX

      
Serial Number 98074924
Status Registered
Filing Date 2023-07-07
Registration Date 2025-11-04
Owner Hemerus Medical, LLC ()
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

Medical devices, namely, kits for the collection, anticoagulation or storage of whole blood, comprised of medical tubing for transfusions, empty blood storage bags, and anticoagulation chemical solutions and chemical storage solutions for storing whole blood for medical purposes

51.

Bracket, thrombelastography device, and support system

      
Application Number 18169531
Grant Number 11835512
Status In Force
Filing Date 2023-02-15
First Publication Date 2023-06-22
Grant Date 2023-12-05
Owner Haemonetics Corporation (USA)
Inventor
  • Xiao, Jian
  • Yu, Bangzhong
  • Jiang, Feng

Abstract

A bracket, a thrombelastography device, and a support system are disclosed. The bracket comprises: a fixed support part (101), a movable support part (102), and a connection part (103). The connection part comprises a first fixing connection member (1031) and a second fixing connection member (1032). The first fixing connection member is fixedly connected to the fixed support part; the second fixing connection member is fixedly connected to the movable support part; the first fixing connection member is connected to the second fixing connection member in point contact fashion, such that the first fixing connection member and the second fixing connection member can rotate relative to each other; the movable support part is fixedly connected to a supported object; when driven by the supported object, the movable support part rotates relative to the fixed support part by means of the point contact between the first fixing connection member and the second fixing connection member. The thrombelastography device comprises a rotational shaft and a bracket. The rotational resistance to the supported object when it rotates can be reduced.

IPC Classes  ?

  • G01N 33/49 - Physical analysis of biological material of liquid biological material blood
  • G01N 11/14 - Investigating flow properties of materials, e.g. viscosity or plasticityAnalysing materials by determining flow properties by moving a body within the material by using rotary bodies, e.g. vane
  • G01N 33/86 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving blood coagulating time
  • G01N 11/06 - Investigating flow properties of materials, e.g. viscosity or plasticityAnalysing materials by determining flow properties by measuring flow of the material through a restricted passage, e.g. tube, aperture by timing the outflow of a known quantity
  • G01N 11/16 - Investigating flow properties of materials, e.g. viscosity or plasticityAnalysing materials by determining flow properties by moving a body within the material by measuring damping effect upon oscillatory body

52.

System and method for collecting plasma

      
Application Number 17943410
Grant Number 11738124
Status In Force
Filing Date 2022-09-13
First Publication Date 2023-01-05
Grant Date 2023-08-29
Owner Haemonetics Corporation (USA)
Inventor Ragusa, Michael

Abstract

A method for collecting plasma includes determining the weight and hematocrit of a donor, and inserting a venous-access device into the donor. The method then withdraws blood from the donor through a draw line connected to a blood component separation device, and introduces anticoagulant into the withdrawn blood. The blood component separation device separates the blood into a plasma component and a second blood component, and the plasma component is collected from the blood component separation device and into a plasma collection container. The method may then calculate (1) a percentage of anticoagulant in the collected plasma component, and (2) a volume of pure plasma collected within the plasma collection container. The volume of pure plasma may be based, at least in part, on the calculated percentage of anticoagulant. The method may continue until a target volume of pure plasma is collected within the plasma collection container.

IPC Classes  ?

  • A61M 1/02 - Blood transfusion apparatus
  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
  • A61M 1/38 - Removing constituents from donor blood and returning remainder to body
  • G01N 15/05 - Investigating sedimentation of particle suspensions in blood

53.

Method and retainer for hemostasis testing

      
Application Number 17855634
Grant Number 12005449
Status In Force
Filing Date 2022-06-30
First Publication Date 2022-11-03
Grant Date 2024-06-11
Owner Haemonetics Corporation (USA)
Inventor
  • Delmenico, Peter
  • Lopez-Espina, Carlos G.
  • Raviv, Gabriel

Abstract

A sample testing cartridge is usable to perform a variety of tests on a visco-elastic sample, such hemostasis testing on a whole blood or blood component sample. The cartridge includes a sample processing portion that is in fluid communication with a sample retention structure. A suspension, such as a beam, arm, cantilever or similar structure supports or suspends the sample retention portion relative to the sample processing portion in a unitary structure. In this manner, the sample retention portion may be placed into dynamic excitation responsive to excitation of the cartridge and correspondingly dynamic, resonant excitation of the sample contained within the sample retention portion, while the sample processing portion remains fixed. Observation of the excited sample yields data indicative of hemostasis. The data may correspond to hemostasis parameters such as time to initial clot formation, rate of clot formation, maximum clot strength and degree of clot lysis.

IPC Classes  ?

  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
  • G01N 11/16 - Investigating flow properties of materials, e.g. viscosity or plasticityAnalysing materials by determining flow properties by moving a body within the material by measuring damping effect upon oscillatory body
  • G01N 29/032 - Analysing fluids by measuring attenuation of acoustic waves
  • G01N 29/036 - Analysing fluids by measuring frequency or resonance of acoustic waves
  • G01N 29/24 - Probes
  • G01N 33/49 - Physical analysis of biological material of liquid biological material blood

54.

SYSTEM AND SOLUTION FOR IMPROVED WHOLE BLOOD STORAGE

      
Application Number US2022023844
Publication Number 2022/216937
Status In Force
Filing Date 2022-04-07
Publication Date 2022-10-13
Owner HEMERUS MEDICAL, LLC (USA)
Inventor
  • Hess, John
  • Zia, Majid

Abstract

A whole blood storage system that includes whole blood leukoreduction with pH optimization for improved RBC storage. Such a system can provide leukoreduced whole blood for field medical use, but would preserve the RBCs and most plasma coagulation activity for at least about 2 weeks, or about 3 weeks, or about 4 weeks, or about 5 weeks or about 6 weeks so that the units would not go to waste.

IPC Classes  ?

  • A01N 1/00 - Preservation of bodies of humans or animals, or parts thereof
  • A01N 1/02 - Preservation of living parts
  • A61K 35/14 - BloodArtificial blood

55.

SYSTEM AND SOLUTION FOR IMPROVED WHOLE BLOOD STORAGE

      
Document Number 03213799
Status Pending
Filing Date 2022-04-07
Open to Public Date 2022-10-13
Owner HEMERUS MEDICAL, LLC (USA)
Inventor
  • Hess, John
  • Zia, Majid

Abstract

A whole blood storage system that includes whole blood leukoreduction with pH optimization for improved RBC storage. Such a system can provide leukoreduced whole blood for field medical use, but would preserve the RBCs and most plasma coagulation activity for at least about 2 weeks, or about 3 weeks, or about 4 weeks, or about 5 weeks or about 6 weeks so that the units would not go to waste.

IPC Classes  ?

  • A01N 1/00 - Preservation of bodies of humans or animals, or parts thereof
  • A61K 35/14 - BloodArtificial blood

56.

HEMOSTASIS MEASUREMENT DEVICE QUALITY CONTROL FORMULATIONS

      
Application Number US2022021687
Publication Number 2022/212162
Status In Force
Filing Date 2022-03-24
Publication Date 2022-10-06
Owner HAEMONETICS CORPORATION (USA)
Inventor Qian, Xiaohua

Abstract

Quality control formulations that do not require human donor-derived blood components for use in testing the efficacy of viscoelastic analysis reagents, and methods for preparing these formulations, are described.

IPC Classes  ?

  • G01N 33/53 - ImmunoassayBiospecific binding assayMaterials therefor
  • G01N 24/08 - Investigating or analysing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance

57.

Hemostasis measurement device quality control formulations

      
Application Number 17703354
Grant Number 11906532
Status In Force
Filing Date 2022-03-24
First Publication Date 2022-10-06
Grant Date 2024-02-20
Owner Haemonetics Corporation (USA)
Inventor Qian, Xiaohua

Abstract

Quality control formulations that do not require human donor-derived blood components for use in testing the efficacy of viscoelastic analysis reagents, and methods for preparing these formulations, are described.

IPC Classes  ?

  • G01N 31/00 - Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroupsApparatus specially adapted for such methods
  • G01N 33/53 - ImmunoassayBiospecific binding assayMaterials therefor
  • G01N 33/96 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving blood or serum control standard

58.

Thrombelastography device, heating apparatus, blood coagulation analysis system and rotational angle measurement method

      
Application Number 17748679
Grant Number 11927587
Status In Force
Filing Date 2022-05-19
First Publication Date 2022-09-08
Grant Date 2024-03-12
Owner Haemonetics Corporation (USA)
Inventor
  • Xiao, Jian
  • Chen, Aiqin
  • Yu, Bangzhong
  • Jiang, Feng

Abstract

A thrombelastography device, a heating apparatus, a blood coagulation analysis system, and a rotational angle measurement method are disclosed. The thrombelastography device consists of a plurality of thrombelastography device splits (2) that are horizontally arranged in parallel. The thrombelastography device split (2) comprises a worktable (4), a rack (5), a test bar (6), a tester (8), and a processor (9). The thrombelastography device overcomes the defect in the prior art that the measurement result of a thrombelastography device is inaccurate. The amount of reflected light is used as a reference for thrombelastographic evaluation, and thus the result is more accurate.

IPC Classes  ?

  • G01N 33/49 - Physical analysis of biological material of liquid biological material blood
  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
  • B01L 7/00 - Heating or cooling apparatusHeat insulating devices
  • B01L 9/02 - Laboratory benches or tablesFittings therefor
  • G01N 11/00 - Investigating flow properties of materials, e.g. viscosity or plasticityAnalysing materials by determining flow properties
  • G01N 11/14 - Investigating flow properties of materials, e.g. viscosity or plasticityAnalysing materials by determining flow properties by moving a body within the material by using rotary bodies, e.g. vane

59.

Methods and devices for the enrichment of immunoglobulin from blood

      
Application Number 17564976
Grant Number 12668609
Status In Force
Filing Date 2021-12-29
First Publication Date 2022-04-21
Grant Date 2026-06-30
Owner Haemonetics Corporation (USA)
Inventor Sowemimo-Coker, Samuel O.

Abstract

A method for extracting at least 55% of immunoglobulin such as IgG from a biological fluid. The biological fluid containing immunoglobulin is contacted with a solid support covalently bonded to a ligand that specifically binds to immunoglobulin under conditions sufficient for non-covalent binding of immunoglobulin to the ligand. The solid support is contacted with an elution solution under conditions whereby the non-covalently bound immunoglobulin is released from the ligand and into the elution solution, wherein at least 55% of the IgG present in the biological fluid is extracted into the elution solution. The method, in some embodiments, provides a method for enriching immunoglobulin from a biological fluid comprising obtaining an initial biological fluid suspected of containing immunoglobulin and removing non-immunoglobulin components naturally occurring in the initial biological fluid to obtain a non-immunoglobulin component-reduced biological fluid.

IPC Classes  ?

  • A61K 39/395 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum
  • A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration
  • C07K 1/14 - ExtractionSeparationPurification

60.

System and method for measuring pressure of fluid flow

      
Application Number 17513322
Grant Number 11802802
Status In Force
Filing Date 2021-10-28
First Publication Date 2022-02-17
Grant Date 2023-10-31
Owner Haemonetics Corporation (USA)
Inventor
  • Lei, Ming
  • Murphy, Matthew

Abstract

An apparatus for measuring pressure within a fluid path includes a housing defining the structure of the apparatus. The housing includes a fluid path that extends through the housing and allows a fluid to pass through the housing. The apparatus also includes a first volume chamber that is in fluid communication with the fluid path and has a first volume chamber opening, and a second volume chamber with a second volume chamber opening that is less than the first volume chamber opening. A diaphragm separates the first volume chamber from the second volume chamber and fluidly disconnects the second volume chamber from the fluid path. The diaphragm deforms based upon the pressure within the fluid path. The apparatus also includes an interface that is connectable to a pressure sensor, and the second volume chamber is in fluid communication with the interface.

IPC Classes  ?

  • G01L 7/08 - Measuring the steady or quasi-steady pressure of a fluid or a fluent solid material by mechanical or fluid pressure-sensitive elements in the form of elastically-deformable gauges of the flexible-diaphragm type
  • G01L 19/06 - Means for preventing overload or deleterious influence of the measured medium on the measuring device or vice versa
  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
  • G01L 19/00 - Details of, or accessories for, apparatus for measuring steady or quasi-steady pressure of a fluent medium insofar as such details or accessories are not special to particular types of pressure gauges
  • A61B 5/00 - Measuring for diagnostic purposes Identification of persons
  • A61B 5/021 - Measuring pressure in heart or blood vessels

61.

System and method for enhancing plasma acquisition at a plasma donation center

      
Application Number 17271510
Grant Number 12437861
Status In Force
Filing Date 2019-08-26
First Publication Date 2021-11-25
Grant Date 2025-10-07
Owner Haemonetics Corporation (USA)
Inventor Tan, Melvin

Abstract

A method for engaging a donor includes receiving, in a server, donor information and donation data for the donor, and sending a first communication to the donor. The first communication may be sent to the donor after completion of a donation and the method may monitor a time period after the donation to determine when a predetermined period of time has passed. The method may then generate and send a second communication to the donor after the passage of the predetermined time period. The second communication may remind the donor of that the donor is eligible to donate again and may include a preferred date and time for the donor to return to donate again. The preferred date and time may be based, at least in part, on heuristic information about the donation center's productivity. The method may also generate/send an additional message requesting a referral from the donor.

IPC Classes  ?

  • G16H 40/20 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
  • A63F 13/79 - Game security or game management aspects involving player-related data, e.g. identities, accounts, preferences or play histories
  • G06Q 30/0207 - Discounts or incentives, e.g. coupons or rebates
  • G06Q 30/0214 - Referral reward systems
  • G06Q 30/0226 - Incentive systems for frequent usage, e.g. frequent flyer miles programs or point systems
  • G06Q 50/00 - Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
  • G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
  • H04L 67/12 - Protocols specially adapted for proprietary or special-purpose networking environments, e.g. medical networks, sensor networks, networks in vehicles or remote metering networks

62.

SYSTEM AND METHOD FOR CREATING CELL PROCESSING PROTOCOLS

      
Application Number 17274251
Status Pending
Filing Date 2019-09-11
First Publication Date 2021-11-18
Owner Haemonetics Corporation (USA)
Inventor Kasper, Seth

Abstract

A method for creating a custom cell processing protocol includes providing a cell processing device having a display, a blood component separation device, and a pump. The method may then select, using the display, a first and second processing phase. The first processing phase has a plurality of first processing phase parameters and the second processing phase has a plurality of second processing phase parameters. The method may then modify the first and second processing phase parameters using the display, and create a custom protocol algorithm. The algorithm may be based, at least in part, on the selected first and second processing phases and the modified first and second processing phase parameters

IPC Classes  ?

  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
  • A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration
  • B04B 5/04 - Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers
  • B04B 13/00 - Control arrangements specially designed for centrifugesProgramme control of centrifuges
  • G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
  • G16H 40/40 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
  • G05B 13/02 - Adaptive control systems, i.e. systems automatically adjusting themselves to have a performance which is optimum according to some preassigned criterion electric

63.

SYSTEM AND METHOD FOR REMOTELY OBTAINING DONOR INFORMATION

      
Application Number 17271473
Status Pending
Filing Date 2019-08-26
First Publication Date 2021-10-28
Owner Haemonetics Corporation (USA)
Inventor Tan, Melvin

Abstract

A method for remotely obtaining donor information includes identifying a donor after receiving donor specific information from the donor at a remote location and retrieving, at a plasma center, a donor questionnaire based, at least in part, on the donor specific information. The method may then present at least one question from the questionnaire to the donor at the remote location and receive at least one response to question(s) from the donor. Upon receipt of the response(s), the method processes the response(s) at the plasma center and assesses a result of the processed responses to achieve a result assessment based on the at least one response. The assessment may be either a passing assessment or a non-passing assessment. The method may then encode, if the assessment is a passing assessment, the assessment and provide the donor with the encoded assessment.

IPC Classes  ?

  • G16H 10/65 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records stored on portable record carriers, e.g. on smartcards, RFID tags or CD
  • G16H 10/20 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
  • G06K 19/06 - Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
  • G06K 19/07 - Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards with integrated circuit chips
  • G16H 40/20 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
  • G06K 7/14 - Methods or arrangements for sensing record carriers by electromagnetic radiation, e.g. optical sensingMethods or arrangements for sensing record carriers by corpuscular radiation using light without selection of wavelength, e.g. sensing reflected white light
  • G06K 9/00 - Methods or arrangements for reading or recognising printed or written characters or for recognising patterns, e.g. fingerprints

64.

HEALTH CARE PROVIDER DATA SYSTEMS PROCESSING AND ANALYTICS

      
Application Number 17271194
Status Pending
Filing Date 2019-08-26
First Publication Date 2021-10-28
Owner Haemonetics Corporation (USA)
Inventor
  • Tan, Melvin
  • Odeen, James
  • Cairns, Christopher
  • Sheehan, Ronald

Abstract

A method for generating a directive for maintaining an objective includes integrating a control center system with a plurality of healthcare provider data systems and obtaining information from the healthcare provider data system(s). The method may then use artificial intelligence to correlate the obtained information against an identified business objective of a donation center and generate, using a heuristic model, a directive to the donation center(s) to achieve the identified business objective. The method may then present the directive a user and/or user system such that the directive may carried out.

IPC Classes  ?

  • G16H 40/20 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
  • G16H 40/40 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
  • G06Q 10/06 - Resources, workflows, human or project managementEnterprise or organisation planningEnterprise or organisation modelling
  • G06N 5/00 - Computing arrangements using knowledge-based models

65.

Plasmapheresis centrifuge bowl

      
Application Number 17349966
Grant Number 12409262
Status In Force
Filing Date 2021-06-17
First Publication Date 2021-10-07
Grant Date 2025-09-09
Owner Haemonetics Corporation (USA)
Inventor Korytko, Taylor

Abstract

A plasmapheresis bowl for the separation and collection of plasma includes a core and a feed tube that increase the bowl efficiency and reduce foaming within the plasma. The core may have a cylindrical body and a ledge located within the interior of the core. The ledge extends radially inward from the core and defines, at least partially, a collection chamber within the plasmapheresis bowl. The core also has ribs that extend above the top of core body and create flow paths that allow fluid to enter the interior of the cylindrical body and collection chamber. The feed tube has a flow path extending through it that fluidly connects an inlet port on the plasmapheresis centrifuge. A first skirt member on the feed tube has a smooth angled surface that helps to reduce foaming.

IPC Classes  ?

  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
  • A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration
  • B04B 5/04 - Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers
  • B04B 7/08 - Rotary bowls

66.

System and method for measuring volume and pressure

      
Application Number 17351042
Grant Number 11592348
Status In Force
Filing Date 2021-06-17
First Publication Date 2021-10-07
Grant Date 2023-02-28
Owner Haemonetics Corporation (USA)
Inventor Stacey, Gary

Abstract

A volume measurement system for a fluid processing device includes a fluid container, an imaging unit, and a controller. The container includes a housing defining the structure of the fluid container, and a plurality of fluid chambers. The fluid chambers collect and/or store fluid from the fluid processing device, and each have a port that allows fluid to enter and/or exit the fluid chambers. The imaging unit takes images of the fluid chambers and is positioned to view a level of fluid in each of the chambers. The controller is in communication with the imaging unit and determines the volume of fluid within each of the fluid chambers based upon the viewed level of fluid in the fluid chambers.

IPC Classes  ?

  • G01L 11/02 - Measuring steady or quasi-steady pressure of a fluid or a fluent solid material by means not provided for in group or by optical means
  • G01F 23/292 - Light
  • G01L 19/00 - Details of, or accessories for, apparatus for measuring steady or quasi-steady pressure of a fluent medium insofar as such details or accessories are not special to particular types of pressure gauges
  • G01F 22/02 - Methods or apparatus for measuring volume of fluids or fluent solid material, not otherwise provided for involving measurement of pressure

67.

Y-connector for blood processing system and disposable set containing same

      
Application Number 17322015
Grant Number 11844894
Status In Force
Filing Date 2021-05-17
First Publication Date 2021-09-02
Grant Date 2023-12-19
Owner Haemonetics Corporation (USA)
Inventor Mcdowell, Christopher S.

Abstract

A tubing set for a blood processing system includes a first connector, a first tube, and a second tube. The first connector is configured to connect to a separation device within the blood processing system, and has a first inlet configured to be fluidly connected to an outlet of the separation device. The first connector also has an outlet and a second inlet. The first tube fluidly connects to the outlet and fluidly connects the separation device and a blood component storage container. The second tube is fluidly connected to the second inlet and fluidly connects the separation device and a saline storage container. The second tube may include a second connector that connects to the saline storage container.

IPC Classes  ?

  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
  • A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration
  • G01N 1/10 - Devices for withdrawing samples in the liquid or fluent state
  • A61M 39/04 - Access sites having pierceable self-sealing members
  • A61M 39/08 - TubesStorage means specially adapted therefor
  • A61M 39/20 - Closure caps or plugs for connectors or open ends of tubes
  • G01N 33/48 - Biological material, e.g. blood, urineHaemocytometers
  • A61M 39/02 - Access sites

68.

PLATELETMAPPING

      
Serial Number 97004026
Status Registered
Filing Date 2021-08-31
Registration Date 2023-06-13
Owner Haemonetics Corporation ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

medical diagnostic assay for testing blood

69.

Apheresis devices fleet management system and method

      
Application Number 17271144
Grant Number 12620480
Status In Force
Filing Date 2019-08-26
First Publication Date 2021-08-12
Grant Date 2026-05-05
Owner Haemonetics Corporation (USA)
Inventor Tan, Melvin

Abstract

A fleet management system includes apheresis devices and a fleet management device remotely located from and in communication with the apheresis devices. Each apheresis device has a controller, firmware and firmware settings. The fleet management device includes an interface to allow a user to interact with the fleet management device, a server and a processor. The server receives information regarding the firmware/firmware settings of each of the apheresis devices and a firmware file from the user and/or a remote repository. The processor processes the information to determine which of the apheresis devices requires an update to the firmware/firmware settings. The server then distributes the firmware file to each apheresis device that requires the update. The system may also develop a fleet model for one or more donation centers that includes a recommend quantity of devices for the location(s) and/or whether devices should be moved from one location to another.

IPC Classes  ?

  • G16H 40/40 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
  • G06F 8/65 - Updates
  • G06F 8/71 - Version control Configuration management
  • G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
  • G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

70.

Detection of Reversal of an Anticoagulant Using a Clotting Assay

      
Application Number 17182964
Status Pending
Filing Date 2021-02-23
First Publication Date 2021-07-29
Owner Haemonetics Corporation (USA)
Inventor
  • Zaman, Fowzia S.
  • Doubleday, Marc

Abstract

In some embodiments, the invention provides methods for detecting the reversal an anticoagulant at a therapeutically relevant amount or higher in a patient, including subjecting a sample of a control blood component (known not to contain the anticoagulant) to a clotting assay in the presence of an ecarin reagent to obtain a control ecarin clotting measurement; subjecting a sample of a control blood component (known not to contain the anticoagulant) to a clotting assay in the presence of a Factor Xa reagent to obtain a control Factor Xa clotting measurement; subjecting a sample of a blood component from a patient suspected to contain a reversal agent to a clotting assay in the presence of the ecarin reagent to obtain a patient ecarin clotting measurement; subjecting a sample of a blood component from the patient suspected to contain the reversal agent to a clotting assay in the presence of the Factor Xa reagent to obtain a patient Factor Xa clotting measurement; and comparing the control ecarin clotting measurement to the patient ecarin clotting measurement and comparing the control Factor Xa clotting measurement to the patient Factor Xa measurement.

IPC Classes  ?

  • C12Q 1/56 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
  • G01N 33/86 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving blood coagulating time

71.

System and method for collecting plasma

      
Application Number 17205374
Grant Number 12171916
Status In Force
Filing Date 2021-03-18
First Publication Date 2021-07-08
Grant Date 2024-12-24
Owner Haemonetics Corporation (USA)
Inventor Ragusa, Michael

Abstract

A method for collecting plasma includes determining the weight and hematocrit of a donor, and inserting a venous-access device into the donor. The method then withdraws blood from the donor through a draw line connected to a blood component separation device, and introduces anticoagulant into the withdrawn blood. The blood component separation device separates the blood into a plasma component and a second blood component, and the plasma component is collected from the blood component separation device and into a plasma collection container. The method may then calculate (1) a percentage of anticoagulant in the collected plasma component, and (2) a volume of pure plasma collected within the plasma collection container. The volume of pure plasma may be based, at least in part, on the calculated percentage of anticoagulant. The method may continue until a target volume of pure plasma is collected within the plasma collection container.

IPC Classes  ?

  • A61M 1/02 - Blood transfusion apparatus
  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
  • A61M 1/38 - Removing constituents from donor blood and returning remainder to body
  • G01N 15/05 - Investigating sedimentation of particle suspensions in blood

72.

System and method for collecting plasma

      
Application Number 17205400
Grant Number 12186474
Status In Force
Filing Date 2021-03-18
First Publication Date 2021-07-08
Grant Date 2025-01-07
Owner Haemonetics Corporation (USA)
Inventor Ragusa, Michael

Abstract

A method for collecting plasma includes determining the weight, height, and hematocrit of a donor, and calculating a donor plasma volume and a target plasma collection volume. The target plasma collection volume is based on the donor plasma volume and a target percentage of plasma. The method then withdraws blood from the donor through a line connected to a blood component separation device, and introduces anticoagulant into the withdrawn blood. The blood component separation device separates the blood into a plasma component and a second blood component, and the plasma component is collected from the blood component separation device and into a plasma collection container. The method may then calculate the volume of pure plasma collected within the plasma collection container, and continue processing/collecting until the calculated volume of pure plasma equals the target plasma collection volume.

IPC Classes  ?

  • A61M 1/38 - Removing constituents from donor blood and returning remainder to body
  • A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration
  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation

73.

Cap removal device and thrombelastography device having same

      
Application Number 17006535
Grant Number 11866311
Status In Force
Filing Date 2020-08-28
First Publication Date 2021-01-07
Grant Date 2024-01-09
Owner Haemonetics Corporation (USA)
Inventor
  • Jiang, Feng
  • Xiao, Jian
  • Liu, Gong
  • Chen, Aiqin
  • Yu, Bangzhong

Abstract

A cap removal device and a thrombelastography device having same are disclosed. The cap removal device comprises a drive part (1), a connection shaft (2), and a cap removal member (3). The connection shaft (2) can move upward when driven by the drive part (1). The cap removal member (3) has an end (31) and the other end (32); the end (31) is pivotally connected to the connection shaft (2), so that when the connection shaft (2) moves upward when driven by the drive part (1), the cap removal member (3) rotates, due to the upward movement, around a pivot point (4) located between the end (31) and the other end (32) of the cap removal member (3), so that the other end (32) of the cap removal member (3) moves downward to contact a cap (5) to be removed, thereby removing the cap (5). The thrombelastography device has the cap removal device, and thus can achieve the automatic removal of the cap (5) and the automated control on the drive part (1), thereby improving the cap removal efficiency and the test efficiency, and saving time of manually removing the cap.

IPC Classes  ?

  • G01N 33/86 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving blood coagulating time
  • G01N 33/49 - Physical analysis of biological material of liquid biological material blood
  • B67B 3/28 - Mechanisms for causing relative movement between bottle or jar and capping head

74.

Continuous flow separation chamber

      
Application Number 17029929
Grant Number 11660384
Status In Force
Filing Date 2020-09-23
First Publication Date 2021-01-07
Grant Date 2023-05-30
Owner Haemonetics Corporation (USA)
Inventor
  • Murphy, Matthew
  • Uhlmann, Dominique
  • Powers, Edward
  • Ragusa, Michael
  • Pagès, Etienne

Abstract

A continuous flow centrifuge bowl includes a rotatable outer body, and a top and bottom core that are rotatable with the outer body. The bottom core has a wall extending proximally from a bottom wall. The proximally extending wall is radially outward from at least a portion of the top core and, together with the top core, defines a primary separation region in which initial separation of the whole blood occurs. The bowl may also have a secondary separation region located between the top core and the outer body, and a rotary seal that couples an inlet port and two outlet ports to the outer body. The inlet port may be connected to an inlet tube that extends distally into a whole blood introduction region. Additionally, one of the outlet ports may be connected to an extraction tube that extends into a region below the bottom core.

IPC Classes  ?

  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
  • B04B 5/04 - Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers
  • B04B 13/00 - Control arrangements specially designed for centrifugesProgramme control of centrifuges

75.

Bracket, thrombelastography device, and support system

      
Application Number 17006523
Grant Number 11598764
Status In Force
Filing Date 2020-08-28
First Publication Date 2020-12-17
Grant Date 2023-03-07
Owner HAEMONETICS CORPORATION (USA)
Inventor
  • Xiao, Jian
  • Yu, Bangzhong
  • Jiang, Feng

Abstract

A bracket, a thrombelastography device, and a support system are disclosed. The device comprises: a fixed support part (101), a movable support part (102), and a connection part (103). The connection part comprises a first fixing connection member (1031) and a second fixing connection member (1032). The first fixing connection member is fixedly connected to the fixed support part; the second fixing connection member is fixedly connected to the movable support part; the first fixing connection member is connected to the second fixing connection member in point contact fashion, such that the first fixing connection member and the second fixing connection member can rotate relative to each other; the movable support part is fixedly connected to a supported object; when driven by the supported object, the movable support part rotates relative to the fixed support part by means of the point contact between the first fixing connection member and the second fixing connection member. The thrombelastography device comprises a rotational shaft and a bracket. The rotational resistance to the supported object when it rotates can be reduced.

IPC Classes  ?

  • G01N 33/49 - Physical analysis of biological material of liquid biological material blood
  • G01N 11/14 - Investigating flow properties of materials, e.g. viscosity or plasticityAnalysing materials by determining flow properties by moving a body within the material by using rotary bodies, e.g. vane
  • G01N 11/16 - Investigating flow properties of materials, e.g. viscosity or plasticityAnalysing materials by determining flow properties by moving a body within the material by measuring damping effect upon oscillatory body
  • G01N 33/86 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving blood coagulating time

76.

System and method for collecting plasma

      
Application Number 16931333
Grant Number 10980934
Status In Force
Filing Date 2020-07-16
First Publication Date 2020-11-05
Grant Date 2021-04-20
Owner HAEMONETICS CORPORATION (USA)
Inventor Ragusa, Michael

Abstract

A method for collecting plasma includes determining the weight, height, and hematocrit of a donor, and calculating a donor plasma volume and a target plasma collection volume. The target plasma collection volume is based on the donor plasma volume and a target percentage of plasma. The method then withdraws blood from the donor through a line connected to a blood component separation device, and introduces anticoagulant into the withdrawn blood. The blood component separation device separates the blood into a plasma component and a second blood component, and the plasma component is collected from the blood component separation device and into a plasma collection container. The method may then calculate the volume of pure plasma collected within the plasma collection container, and continue processing/collecting until the calculated volume of pure plasma equals the target plasma collection volume.

IPC Classes  ?

  • A61M 1/38 - Removing constituents from donor blood and returning remainder to body
  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
  • A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration

77.

PERSONA

      
Application Number 1553642
Status Registered
Filing Date 2020-08-21
Registration Date 2020-08-21
Owner Haemonetics Corporation (USA)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Downloadable and recorded computer software for use in operation of blood and blood plasma processing equipment. Blood and blood plasma processing equipment for medical use.

78.

System and method for collecting plasma

      
Application Number 16866078
Grant Number 10980926
Status In Force
Filing Date 2020-05-04
First Publication Date 2020-08-20
Grant Date 2021-04-20
Owner HAEMONETICS CORPORATION (USA)
Inventor Ragusa, Michael

Abstract

A method for collecting plasma includes determining the weight and hematocrit of a donor, and inserting a venous-access device into the donor. The method then withdraws blood from the donor through a draw line connected to a blood component separation device, and introduces anticoagulant into the withdrawn blood. The blood component separation device separates the blood into a plasma component and a second blood component, and the plasma component is collected from the blood component separation device and into a plasma collection container. The method may then calculate (1) a percentage of anticoagulant in the collected plasma component, and (2) a volume of pure plasma collected within the plasma collection container. The volume of pure plasma may be based, at least in part, on the calculated percentage of anticoagulant. The method may continue until a target volume of pure plasma is collected within the plasma collection container.

IPC Classes  ?

  • A61M 1/02 - Blood transfusion apparatus
  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
  • A61M 1/38 - Removing constituents from donor blood and returning remainder to body
  • G01N 15/05 - Investigating sedimentation of particle suspensions in blood

79.

DONOR360

      
Serial Number 90054446
Status Registered
Filing Date 2020-07-15
Registration Date 2021-09-14
Owner Haemonetics Corporation ()
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

Downloadable computer application software for mobile phones and computers, namely, downloadable software for use by potential blood or plasma donors to see donation history, find donation drives and schedule appointments, receive education about the donation process, complete health history questionnaires, receive notification of use of donated blood or plasma; downloadable computer application software for mobile phones and computers, namely, downloadable software for use by blood or plasma donation center operators for donation trend analysis, to target and identify donors and prospective donors for marketing message outreach via social media, e-mail, or SMS, conduct donor surveys, and for providing information about the donor to donation center workers to enhance the donor's in-center experience; computer application software for mobile phones and computers, namely, recorded software for use by potential blood or plasma donors to see donation history, find donation drives and schedule appointments, receive education about the donation process, complete health history questionnaires, receive notification of use of donated blood or plasma; computer application software for mobile phones and computers, namely, recorded software for use by blood or plasma donation center operators for donation trend analysis, to target and identify donors and prospective donors for marketing message outreach via social media, e-mail, or SMS, conduct donor surveys, and for providing information about the donor to donation center workers to enhance the donor's in-center experience

80.

MCS

      
Application Number 1535215
Status Registered
Filing Date 2020-05-13
Registration Date 2020-05-13
Owner Haemonetics Corporation (USA)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

Blood processing equipment for medical use.

81.

TEG MANAGER

      
Application Number 1528828
Status Registered
Filing Date 2020-03-31
Registration Date 2020-03-31
Owner Haemonetics Corporation (USA)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

Computer software for use in operation of blood coagulation testing devices.

82.

PCS

      
Application Number 1528726
Status Registered
Filing Date 2020-03-31
Registration Date 2020-03-31
Owner HAEMONETICS CORPORATION (USA)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

Automated blood collection and separation units for a wide variety of medical uses.

83.

PERSONA

      
Application Number 018229306
Status Registered
Filing Date 2020-04-23
Registration Date 2020-08-25
Owner Haemonetics Corporation (USA)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Computer software for use in operation of blood and blood plasma processing equipment. Blood and blood plasma processing equipment for medical use.

84.

PERSONA

      
Application Number 202366500
Status Registered
Filing Date 2020-04-21
Registration Date 2025-04-16
Owner Haemonetics Corporation (USA)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Computer software for use in operation of blood and blood plasma processing equipment and not for use in imaging (2) Blood and blood plasma processing equipment for medical use and not for use in imaging

85.

SYSTEM AND METHOD FOR CREATING CELL PROCESSING PROTOCOLS

      
Application Number US2019050539
Publication Number 2020/055958
Status In Force
Filing Date 2019-09-11
Publication Date 2020-03-19
Owner HAEMONETICS CORPORATION (USA)
Inventor Kasper, Seth

Abstract

A method for creating a custom cell processing protocol includes providing a cell processing device having a display, a blood component separation device, and a pump. The method may then select, using the display, a first and second processing phase. The first processing phase has a plurality of first processing phase parameters and the second processing phase has a plurality of second processing phase parameters. The method may then modify the first and second processing phase parameters using the display, and create a custom protocol algorithm. The algorithm may be based, at least in part, on the selected first and second processing phases and the modified first and second processing phase parameters

IPC Classes  ?

  • A61B 10/02 - Instruments for taking cell samples or for biopsy

86.

APHERESIS DEVICE CONTROLLER

      
Document Number 03110485
Status Pending
Filing Date 2019-08-26
Open to Public Date 2020-03-05
Owner HAEMONETICS CORPORATION (USA)
Inventor Tan, Melvin

Abstract

A controller for a blood processing device has a body that may dock and undock with a first blood processing device to connect the controller to the first blood processing device and disconnect the controller from the first blood processing device. A processor within the controller controls the first blood processing device when the controller is docked with the first blood processing device and remotely controls the first blood processing device when undocked. The controller also has a user interface that displays information regarding the first blood processing device and an ongoing apheresis procedure when the controller is docked to the first blood processing device and when the controller is undocked from the first blood processing device.

IPC Classes  ?

  • A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration
  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation

87.

SYSTEM AND METHOD FOR PLASMA DONOR ENGAGEMENT

      
Document Number 03110493
Status Pending
Filing Date 2019-08-26
Open to Public Date 2020-03-05
Owner HAEMONETICS CORPORATION (USA)
Inventor Tan, Melvin

Abstract

A method for engaging a donor includes receiving, in a server, donor information and donation data for the donor, and sending a first communication to the donor. The first communication may be sent to the donor after completion of a donation and the method may monitor a time period after the donation to determine when a predetermined period of time has passed. The method may then generate and send a second communication to the donor after the passage of the predetermined time period. The second communication may remind the donor of that the donor is eligible to donate again and may include a preferred date and time for the donor to return to donate again. The preferred date and time may be based, at least in part, on heuristic information about the donation center's productivity. The method may also generate/send an additional message requesting a referral from the donor.

IPC Classes  ?

  • G06Q 30/02 - MarketingPrice estimation or determinationFundraising
  • G06Q 30/0207 - Discounts or incentives, e.g. coupons or rebates
  • G16H 40/20 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
  • H04L 67/55 - Push-based network services
  • H04W 4/30 - Services specially adapted for particular environments, situations or purposes

88.

HEALTH CARE PROVIDER DATA SYSTEMS PROCESSING AND ANALYTICS

      
Document Number 03110494
Status Pending
Filing Date 2019-08-26
Open to Public Date 2020-03-05
Owner HAEMONETICS CORPORATION (USA)
Inventor
  • Tan, Melvin
  • Odeen, James
  • Cairns, Christopher
  • Sheehan, Ronald

Abstract

A method for generating a directive for maintaining an objective includes integrating a control center system with a plurality of healthcare provider data systems and obtaining information from the healthcare provider data system(s). The method may then use artificial intelligence to correlate the obtained information against an identified business objective of a donation center and generate, using a heuristic model, a directive to the donation center(s) to achieve the identified business objective. The method may then present the directive a user and/or user system such that the directive may carried out.

IPC Classes  ?

  • G06N 5/01 - Dynamic search techniquesHeuristicsDynamic treesBranch-and-bound
  • G06N 20/00 - Machine learning
  • G06Q 10/0637 - Strategic management or analysis, e.g. setting a goal or target of an organisationPlanning actions based on goalsAnalysis or evaluation of effectiveness of goals
  • G16H 40/20 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms

89.

APHERESIS DEVICES FLEET MANAGEMENT SYSTEM AND METHOD

      
Application Number US2019048092
Publication Number 2020/046788
Status In Force
Filing Date 2019-08-26
Publication Date 2020-03-05
Owner HAEMONETICS CORPORATION (USA)
Inventor Tan, Melvin

Abstract

A fleet management system includes apheresis devices and a fleet management device remotely located from and in communication with the apheresis devices. Each apheresis device has a controller, firmware and firmware settings. The fleet management device includes an interface to allow a user to interact with the fleet management device, a server and a processor. The server receives information regarding the firmware/firmware settings of each of the apheresis devices and a firmware file from the user and/or a remote repository. The processor processes the information to determine which of the apheresis devices requires an update to the firmware/firmware settings. The server then distributes the firmware file to each apheresis device that requires the update. The system may also develop a fleet model for one or more donation centers that includes a recommend quantity of devices for the location(s) and/or whether devices should be moved from one location to another.

IPC Classes  ?

  • G16H 40/40 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
  • A61M 1/00 - Suction or pumping devices for medical purposesDevices for carrying-off, for treatment of, or for carrying-over, body-liquidsDrainage systems
  • G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation

90.

SYSTEM AND METHOD FOR PLASMA DONOR ENGAGEMENT

      
Application Number US2019048146
Publication Number 2020/046816
Status In Force
Filing Date 2019-08-26
Publication Date 2020-03-05
Owner HAEMONETICS CORPORATION (USA)
Inventor Tan, Melvin

Abstract

A method for engaging a donor includes receiving, in a server, donor information and donation data for the donor, and sending a first communication to the donor. The first communication may be sent to the donor after completion of a donation and the method may monitor a time period after the donation to determine when a predetermined period of time has passed. The method may then generate and send a second communication to the donor after the passage of the predetermined time period. The second communication may remind the donor of that the donor is eligible to donate again and may include a preferred date and time for the donor to return to donate again. The preferred date and time may be based, at least in part, on heuristic information about the donation center's productivity. The method may also generate/send an additional message requesting a referral from the donor.

IPC Classes  ?

  • G06Q 10/08 - Logistics, e.g. warehousing, loading or distributionInventory or stock management
  • G06Q 10/10 - Office automationTime management
  • G06Q 50/00 - Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
  • G09B 23/28 - Models for scientific, medical, or mathematical purposes, e.g. full-sized device for demonstration purposes for medicine
  • G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation

91.

HEALTH CARE PROVIDER DATA SYSTEMS PROCESSING AND ANALYTICS

      
Application Number US2019048147
Publication Number 2020/046817
Status In Force
Filing Date 2019-08-26
Publication Date 2020-03-05
Owner HAEMONETICS CORPORATION (USA)
Inventor
  • Tan, Melvin
  • Odeen, James
  • Cairns, Christopher
  • Sheehan, Ronald

Abstract

A method for generating a directive for maintaining an objective includes integrating a control center system with a plurality of healthcare provider data systems and obtaining information from the healthcare provider data system(s). The method may then use artificial intelligence to correlate the obtained information against an identified business objective of a donation center and generate, using a heuristic model, a directive to the donation center(s) to achieve the identified business objective. The method may then present the directive a user and/or user system such that the directive may carried out.

IPC Classes  ?

  • G06Q 50/00 - Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism

92.

APHERESIS DEVICES FLEET MANAGEMENT SYSTEM AND METHOD

      
Document Number 03110490
Status Pending
Filing Date 2019-08-26
Open to Public Date 2020-03-05
Owner HAEMONETICS CORPORATION (USA)
Inventor Tan, Melvin

Abstract

A fleet management system includes apheresis devices and a fleet management device remotely located from and in communication with the apheresis devices. Each apheresis device has a controller, firmware and firmware settings. The fleet management device includes an interface to allow a user to interact with the fleet management device, a server and a processor. The server receives information regarding the firmware/firmware settings of each of the apheresis devices and a firmware file from the user and/or a remote repository. The processor processes the information to determine which of the apheresis devices requires an update to the firmware/firmware settings. The server then distributes the firmware file to each apheresis device that requires the update. The system may also develop a fleet model for one or more donation centers that includes a recommend quantity of devices for the location(s) and/or whether devices should be moved from one location to another.

IPC Classes  ?

  • A61M 1/00 - Suction or pumping devices for medical purposesDevices for carrying-off, for treatment of, or for carrying-over, body-liquidsDrainage systems
  • G16H 40/40 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
  • G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation

93.

SYSTEM AND METHOD FOR REMOTELY OBTAINING DONOR INFORMATION

      
Document Number 03110491
Status Pending
Filing Date 2019-08-26
Open to Public Date 2020-03-05
Owner HAEMONETICS CORPORATION (USA)
Inventor Tan, Melvin

Abstract

A method for remotely obtaining donor information includes identifying a donor after receiving donor specific information from the donor at a remote location and retrieving, at a plasma center, a donor questionnaire based, at least in part, on the donor specific information. The method may then present at least one question from the questionnaire to the donor at the remote location and receive at least one response to question(s) from the donor. Upon receipt of the response(s), the method processes the response(s) at the plasma center and assesses a result of the processed responses to achieve a result assessment based on the at least one response. The assessment may be either a passing assessment or a non-passing assessment. The method may then encode, if the assessment is a passing assessment, the assessment and provide the donor with the encoded assessment.

IPC Classes  ?

  • G06Q 50/22 - Social work or social welfare, e.g. community support activities or counselling services
  • G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records

94.

SYSTEM AND METHOD FOR REMOTELY OBTAINING DONOR INFORMATION

      
Application Number US2019048095
Publication Number 2020/046790
Status In Force
Filing Date 2019-08-26
Publication Date 2020-03-05
Owner HAEMONETICS CORPORATION (USA)
Inventor Tan, Melvin

Abstract

A method for remotely obtaining donor information includes identifying a donor after receiving donor specific information from the donor at a remote location and retrieving, at a plasma center, a donor questionnaire based, at least in part, on the donor specific information. The method may then present at least one question from the questionnaire to the donor at the remote location and receive at least one response to question(s) from the donor. Upon receipt of the response(s), the method processes the response(s) at the plasma center and assesses a result of the processed responses to achieve a result assessment based on the at least one response. The assessment may be either a passing assessment or a non-passing assessment. The method may then encode, if the assessment is a passing assessment, the assessment and provide the donor with the encoded assessment.

IPC Classes  ?

  • G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
  • G06F 19/00 - Digital computing or data processing equipment or methods, specially adapted for specific applications (specially adapted for specific functions G06F 17/00;data processing systems or methods specially adapted for administrative, commercial, financial, managerial, supervisory or forecasting purposes G06Q;healthcare informatics G16H)
  • G06Q 10/00 - AdministrationManagement
  • G06Q 50/22 - Social work or social welfare, e.g. community support activities or counselling services

95.

APHERESIS DEVICE CONTROLLER

      
Application Number US2019048123
Publication Number 2020/046805
Status In Force
Filing Date 2019-08-26
Publication Date 2020-03-05
Owner HAEMONETICS CORPORATION (USA)
Inventor Tan, Melvin

Abstract

A controller for a blood processing device has a body that may dock and undock with a first blood processing device to connect the controller to the first blood processing device and disconnect the controller from the first blood processing device. A processor within the controller controls the first blood processing device when the controller is docked with the first blood processing device and remotely controls the first blood processing device when undocked. The controller also has a user interface that displays information regarding the first blood processing device and an ongoing apheresis procedure when the controller is docked to the first blood processing device and when the controller is undocked from the first blood processing device.

IPC Classes  ?

  • A61M 1/30 - Single needle dialysis
  • A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration
  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
  • A61M 1/38 - Removing constituents from donor blood and returning remainder to body

96.

Detection and classification of an anticoagulant using a clotting assay

      
Application Number 16674334
Grant Number 10954549
Status In Force
Filing Date 2019-11-05
First Publication Date 2020-02-27
Grant Date 2021-03-23
Owner Haemonetics Corporation (USA)
Inventor
  • Zaman, Fowzia S.
  • Doubleday, Marc

Abstract

In some embodiments, the invention provides methods for detecting and/or classifying an anticoagulant at a therapeutically relevant amount or higher in a patient, including subjecting a sample of a control blood component (known not to contain the anticoagulant) to a clotting assay in the presence of a Factor Xa reagent to obtain a control clotting measurement; and subjecting a sample of a blood component from a patient suspected of having the anticoagulant to the clotting assay in the presence of the Factor Xa reagent to obtain a patient clotting measurement, wherein the patient clotting measurement sample greater than the control clotting measurement indicates the presence of the anticoagulant at a therapeutically relevant amount or higher in the patient. In some embodiments, the invention includes methods for classifying an anticoagulant as an anti-Factor Xa or a direct thrombin inhibitor anticoagulant using a clotting assay in the presence of an ecarin reagent.

IPC Classes  ?

  • C12Q 1/56 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
  • G01N 33/86 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving blood coagulating time

97.

PERSONA

      
Serial Number 88798813
Status Registered
Filing Date 2020-02-14
Registration Date 2021-01-26
Owner Haemonetics Corporation (USA)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments

Goods & Services

Downloadable and recorded computer software for use in operation of blood and blood plasma processing equipment blood and blood plasma processing equipment for medical use

98.

SEALER-LESS PLASMA BOTTLE AND TOP FOR SAME

      
Application Number US2019033518
Publication Number 2019/226769
Status In Force
Filing Date 2019-05-22
Publication Date 2019-11-28
Owner HAEMONETICS CORPORATION (USA)
Inventor
  • Mcdowell, Christopher, S.
  • Murphy, Matthew, J.

Abstract

A top for a plasma storage container includes a top body that defines the structure of the top and seals an opening of the plasma storage container. The top also includes a first opening and a vent opening extending through the top body. A valve mechanism is located at least partially within the top body and includes an aperture therethrough. The aperture opens upon connection of a blunt cannula to provide access to the interior of the plasma storage container. The top also includes a vent filter. The vent filter allows air to vent through the vent opening during plasma collection.

IPC Classes  ?

  • A61J 1/14 - Containers specially adapted for medical or pharmaceutical purposes DetailsAccessories therefor

99.

Y-connector for blood processing system and disposable set containing same

      
Application Number 16308848
Grant Number 11135349
Status In Force
Filing Date 2017-06-14
First Publication Date 2019-10-10
Grant Date 2021-10-05
Owner Haemonetics Corporation (USA)
Inventor Mcdowell, Christopher S.

Abstract

A tubing set for a blood processing system includes a first connector, a first tube, and a second tube. The first connector is configured to connect to a separation device within the blood processing system, and has a first inlet configured to be fluidly connected to an outlet of the separation device. The first connector also has an outlet and a second inlet. The first tube fluidly connects to the outlet and fluidly connects the separation device and a blood component storage container. The second tube is fluidly connected to the second inlet and fluidly connects the separation device and a saline storage container. The second tube may include a second connector that connects to the saline storage container.

IPC Classes  ?

  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
  • A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration
  • G01N 1/10 - Devices for withdrawing samples in the liquid or fluent state
  • A61M 39/04 - Access sites having pierceable self-sealing members
  • A61M 39/08 - TubesStorage means specially adapted therefor
  • A61M 39/20 - Closure caps or plugs for connectors or open ends of tubes
  • G01N 33/48 - Biological material, e.g. blood, urineHaemocytometers
  • A61M 39/02 - Access sites

100.

PLASMAPHERESIS CENTRIFUGE BOWL

      
Document Number 03094636
Status Pending
Filing Date 2019-03-20
Open to Public Date 2019-10-03
Owner HAEMONETICS CORPORATION (USA)
Inventor Korytko, Taylor

Abstract

A plasmapheresis bowl for the separation and collection of plasma includes a core and a feed tube that increase the bowl efficiency and reduce foaming within the plasma. The core may have a cylindrical body and a ledge located within the interior of the core. The ledge extends radially inward from the core and defines, at least partially, a collection chamber within the plasmapheresis bowl. The core also has ribs that extend above the top of core body and create flow paths that allow fluid to enter the interior of the cylindrical body and collection chamber. The feed tube has a flow path extending through it that fluidly connects an inlet port on the plasmapheresis centrifuge. A first skirt member on the feed tube has a smooth angled surface that helps to reduce foaming.

IPC Classes  ?

  • A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration
  • A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
  1     2     3        Next Page